» Authors » Cecilia Lugara

Cecilia Lugara

Explore the profile of Cecilia Lugara including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 3
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pepe G, Coco R, Corica D, Luppino G, Morabito L, Lugara C, et al.
Front Endocrinol (Lausanne) . 2024 Nov; 15:1477227. PMID: 39544232
Background: Rett syndrome (RTT) is an X-linked progressive neurodevelopmental disorder that involves mainly girls and is the second most frequent cause of genetic intellectual disability. RTT leads to neurological regression...
2.
Porri D, Luppino G, Aversa T, Corica D, Valenzise M, Messina M, et al.
Front Endocrinol (Lausanne) . 2024 Oct; 15:1426021. PMID: 39363896
Background: Childhood obesity represents a major public health issue worldwide. Evidence showed the need to implement prevention strategies mainly focused on lifestyle habits. Sleep hygiene is a variable of great...
3.
Corica D, Lugara C, Bertherat J, Pasmant E, Valenzise M, Pepe G, et al.
Horm Res Paediatr . 2024 Aug; :1-10. PMID: 39102796
Introduction: Adrenocorticotropic hormone (ACTH)-independent Cushing syndrome (CS) is very rare condition in children. Primary pigmented nodular adrenocortical disease (PPNAD) is a rare cause of CS, which in most cases occurs...
4.
DAmico F, Lugara C, Luppino G, Giuffrida C, Giorgianni Y, Patane E, et al.
Curr Issues Mol Biol . 2024 Mar; 46(3):2528-2543. PMID: 38534776
Neurotrophins (NTs) are four small proteins produced by both neuronal and non-neuronal cells; they include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4). NTs can...
5.
Valenzise M, DAmico F, Tripodi E, Zirilli G, Alibrandi A, Gallizzi R, et al.
Endocrine . 2023 Nov; 84(2):571-576. PMID: 37982947
Purpose: Juvenile Idiopathic Arthritis (JIA) is a chronic inflammatory disease characterized by chronic synovitis, sometimes associated with fever, rash, pericarditis and uveitis. Limited data are available concerning autoimmune diseases associated...
6.
Galletta F, Caminiti L, Lugara C, Foti Randazzese S, Barraco P, DAmico F, et al.
J Pers Med . 2023 Jul; 13(7). PMID: 37511681
Insufficient data are available on the long-term "real-life" safety profile of omalizumab in children. This study evaluated the long-term safety of omalizumab in a pediatric cohort with severe asthma or...